Browse > Article
http://dx.doi.org/10.5483/BMBRep.2018.51.5.196

Imprinted gene Zinc finger protein 127 is a novel regulator of master pluripotency transcription factor, Oct4  

Kwon, Yoo-Wook (Biomedical Research Institute, Seoul National University Hospital)
Ahn, Hyo-Suk (Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University)
Park, Joo-Young (National Research Laboratory for Stem Cell Niche, Seoul National University, Biomedical Research Institute, Seoul National University Hospital)
Yang, Han-Mo (Department of Internal Medicine, Seoul National University Hospital)
Cho, Hyun-Jai (Department of Internal Medicine, Seoul National University Hospital)
Kim, Hyo-Soo (Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University)
Publication Information
BMB Reports / v.51, no.5, 2018 , pp. 242-248 More about this Journal
Abstract
Induced pluripotent stem cells (iPSCs) show great promise for replacing current stem cell therapies in the field of regenerative medicine. However, the original method for cellular reprogramming, involving four exogenous transcription factors, is characterized by low efficiency. Here, we focused on using epigenetic modifications to enhance the reprogramming efficiency. We hypothesized that there would be a new reprogramming factor involved in DNA demethylation, acting on the promoters of pluripotency-related genes. We screened proteins that bind to the methylated promoter of Oct4 and identified Zinc finger protein 127 (Zfp127), the functions of which have not yet been identified. We found that Zfp127 binds to the Oct4 promoter. Overexpression of Zfp127 in fibroblasts induced demethylation of the Oct4 promoter, thus enhancing Oct4 promoter activity and gene expression. These results demonstrate that Zfp127 is a novel regulator of Oct4, and may become a potent target to improve cellular reprogramming.
Keywords
Demethylation; Induced pluripotent stem cells; Oct4; Regenerative medicine; Zinc finger protein 127;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Kwon YW, Paek JS, Cho HJ et al (2015) Role of Zscan4 in secondary murine iPSC derivation mediated by protein extracts of ESC or iPSC. Biomaterials 59, 102-115   DOI
2 Sridharan R, Tchieu J, Mason MJ et al (2009) Role of the murine reprogramming factors in the induction of pluripotency. Cell 136, 364-377   DOI
3 Zhao Y, Yin X, Qin H et al (2008) Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3, 475-479   DOI
4 Silva J, Nichols J, Theunissen TW et al (2009) Nanog is the gateway to the pluripotent ground state. Cell 138, 722-737   DOI
5 Hanna J, Saha K, Pando B et al (2009) Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595-601   DOI
6 Okita K, Nakagawa M, Hyenjong H, Ichisaka T and Yamanaka S (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949-953   DOI
7 Zhou W and Freed CR (2009) Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27, 2667-2674   DOI
8 Miyoshi N, Ishii H, Nagano H et al (2011) Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8, 633-638   DOI
9 Xu N, Papagiannakopoulos T, Pan G, Thomson JA and Kosik KS (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137, 647-658   DOI
10 Cho HJ, Lee CS, Kwon YW et al (2010) Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 116, 386-395   DOI
11 Jong MT, Gray TA, Ji Y et al (1999) A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region. Hum Mol Genet 8, 783-793   DOI
12 Hill PW, Amouroux R and Hajkova P (2014) DNA demethylation, Tet proteins and 5-hydroxymethylcytosine in epigenetic reprogramming: an emerging complex story. Genomics 104, 324-333   DOI
13 Cha MY, Kwon YW, Ahn HS et al (2016) Protein-induced pluripotent stem cells ameliorate cognitive dysfunction and Reduce Abeta deposition in a mouse model of alzheimer's disease. Stem Cells Transl Med 6, 293-305
14 Hattori N, Nishino K, Ko YG et al (2004) Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J Biol Chem 279, 17063-17069   DOI
15 Jin SG, Guo C and Pfeifer GP (2008) GADD45A does not promote DNA demethylation. PLoS Genet 4, e1000013   DOI
16 Imamura M, Miura K, Iwabuchi K et al (2006) Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells. BMC Dev Biol 6, 34   DOI
17 Okita K, Ichisaka T and Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317   DOI
18 Gu P, Xu X, Le Menuet D, Chung AC and Cooney AJ (2011) Differential recruitment of methyl CpG-binding domain factors and DNA methyltransferases by the orphan receptor germ cell nuclear factor initiates the repression and silencing of Oct4. Stem Cells 29, 1041-1051   DOI
19 Eminli S, Foudi A, Stadtfeld M et al (2009) Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 41, 968-976   DOI
20 Buganim Y, Faddah DA, Cheng AW et al (2012) Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150, 1209-1222   DOI
21 Shin J and Youn HD (2016) Oct4 resetting by Aurkb-PP1 cell cycle axis determines the identity of mouse embryonic stem cells. BMB Rep 49, 527-528   DOI
22 Freberg CT, Dahl JA, Timoskainen S and Collas P (2007) Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Mol Biol Cell 18, 1543-1553   DOI
23 Kim D, Kim CH, Moon JI et al (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472-476   DOI
24 Hochedlinger K and Plath K (2009) Epigenetic reprogramming and induced pluripotency. Development 136, 509-523   DOI
25 Jong MT, Carey AH, Caldwell KA et al (1999) Imprinting of a RING zinc-finger encoding gene in the mouse chromosome region homologous to the Prader-Willi syndrome genetic region. Hum Mol Genet 8, 795-803   DOI
26 Sharov AA, Masui S, Sharova LV et al (2008) Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data. BMC Genomics 9, 269   DOI
27 Lee JE, Chung YG, Eum JH, Lee Y and Lee DR (2016) An efficient SCNT technology for the establishment of personalized and public human pluripotent stem cell banks. BMB Rep 49, 197-198   DOI
28 Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY and Blau HM (2010) Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463, 1042-1047   DOI
29 Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920   DOI
30 Takahashi K and Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676   DOI